{
    "organizations": [],
    "uuid": "7e55e400006724269867d691feeb49e319f84d19",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-chabiotech-receives-us-patent/brief-chabiotech-receives-u-s-patent-idUSL3N1R92MP",
    "ord_in_thread": 0,
    "title": "BRIEF-Chabiotech receives U.S. patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Chabiotech Co Ltd :\n* Says it received U.S. patent on March 27, for a method for producing cardiomyocytesfrom human or mouse embryonic stem cellsin amedium consisting of aserum-free medium and N2 supplement\n* Patent number is 13/907,967\nSource text in Korean : goo.gl/dyb6cd\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-27T14:18:00.000+03:00",
    "crawled": "2018-03-28T19:21:25.055+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "chabiotech",
        "co",
        "ltd",
        "say",
        "received",
        "patent",
        "march",
        "method",
        "producing",
        "cardiomyocytesfrom",
        "human",
        "mouse",
        "embryonic",
        "stem",
        "cellsin",
        "amedium",
        "consisting",
        "medium",
        "n2",
        "supplement",
        "patent",
        "number",
        "source",
        "text",
        "korean",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}